BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32865163)

  • 21. Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) polymorphisms in Korean patients with adult acute lymphoblastic leukemia.
    Oh D; Kim NK; Jang MJ; Kim HC; Lee JH; Lee JA; Ahn MJ; Kim CS; Kim HS; Park S; Chio HS; Min YH;
    Anticancer Res; 2007; 27(5A):3419-24. PubMed ID: 17970089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylenetetrahydrofolate reductase gene haplotypes affect toxicity during maintenance therapy for childhood acute lymphoblastic leukemia in Japanese patients.
    Tanaka Y; Manabe A; Nakadate H; Kondoh K; Nakamura K; Koh K; Kikuchi A; Komiyama T
    Leuk Lymphoma; 2014 May; 55(5):1126-31. PubMed ID: 23865834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylenetetrahydrofolate reductase gene polymorphisms: association with risk for pediatric acute lymphoblastic leukemia in north Indians.
    Sood S; Das R; Trehan A; Ahluwalia J; Sachdeva MU; Varma N; Bansal D; Marwaha RK
    Leuk Lymphoma; 2010 May; 51(5):928-32. PubMed ID: 20367562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.
    Faganel Kotnik B; Grabnar I; Bohanec Grabar P; Dolžan V; Jazbec J
    Eur J Clin Pharmacol; 2011 Oct; 67(10):993-1006. PubMed ID: 21509569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
    Aplenc R; Thompson J; Han P; La M; Zhao H; Lange B; Rebbeck T
    Cancer Res; 2005 Mar; 65(6):2482-7. PubMed ID: 15781665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and susceptibility to acute lymphoblastic leukemia in a cohort of Egyptian children.
    Mosaad YM; Abousamra NK; Elashery R; Fawzy IM; Eldein OA; Sherief DM; El Azab HM
    Leuk Lymphoma; 2015; 56(9):2699-705. PubMed ID: 25629981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Association between the methylenetetrahydrofolate reductase gene polymorphisms and haplotype with toxicity response of high dose methotrexate chemotherapy].
    Liao QC; Li XL; Liu ST; Zhang Y; Li TY; Qiu JC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jul; 33(7):735-9. PubMed ID: 22968027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of MTHFR C677T Polymorphism on High-Dose Methotrexate-Related Toxicity in Patients With Primary Central Nervous System Diffuse Large B-Cell Lymphoma.
    Chang X; Guo Y; Su L; Zhang Y; Hui W; Zhao H; Hu R; Sun W
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):91-96. PubMed ID: 33069634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population distribution of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C risk alleles for methotrexate toxicity in Israel.
    Efrati E; Elkin H; Nahum S; Krivoy N
    Rheumatol Int; 2013 Apr; 33(4):1001-4. PubMed ID: 22847291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.
    D'Angelo V; Ramaglia M; Iannotta A; Crisci S; Indolfi P; Francese M; Affinita MC; Pecoraro G; Napolitano A; Fusco C; Oreste M; Indolfi C; Casale F
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1339-46. PubMed ID: 21590445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate.
    van Kooten Niekerk PB; Schmiegelow K; Schroeder H
    Eur J Haematol; 2008 Nov; 81(5):391-8. PubMed ID: 18691257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia.
    Kim NK; Chong SY; Jang MJ; Hong SH; Kim HS; Cho EK; Lee JA; Ahn MJ; Kim CS; Oh D
    Anticancer Res; 2006; 26(4B):2879-81. PubMed ID: 16886608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common Methylenetetrahydrofolate Reductase Polymorphisms (A1298C & C677T) in Ectopic Trophoblasts and Methotrexate Treatment Failure in Tubal Pregnancies.
    Zafer E; Kahraman Cetin N; Turan OD; Kardelen E; Kurt Omurlu I; Yuksel H
    Ginekol Pol; 2018; 89(10):536-540. PubMed ID: 30393840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase, dietary folate intake, and the risk of leukemia in adults.
    Liu P; Zhang M; Xie X; Jin J; Holman CD
    Tumour Biol; 2016 Mar; 37(3):3265-75. PubMed ID: 26438060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
    Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Combined Presence of Hepatitis C Virus and Polymorphisms in Different Genes With Toxicities of Methotrexate and 6-Mercaptopurine in Children With Acute Lymphoblastic Leukemia.
    Abdelaziz DH; Elhosseiny NM; Khaleel SA; Sabry NA; Attia AS; El-Sayed MH
    Pediatr Blood Cancer; 2016 Sep; 63(9):1539-45. PubMed ID: 27163515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients.
    Chiusolo P; Reddiconto G; Farina G; Mannocci A; Fiorini A; Palladino M; La Torre G; Fianchi L; Sorà F; Laurenti L; Leone G; Sica S
    Leuk Res; 2007 Dec; 31(12):1669-74. PubMed ID: 17512587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the methylenetetrahydrofolate reductase 677 and 1298 polymorphisms in Cretan children with acute lymphoblastic leukemia.
    Karathanasis NV; Stiakaki E; Goulielmos GN; Kalmanti M
    Genet Test Mol Biomarkers; 2011; 15(1-2):5-10. PubMed ID: 21117954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between methylenetetrahydrofolate reductase gene polymorphisms and methotrexate drug metabolism and toxicity.
    Tan Y; Kong Q; Li X; Tang Y; Mai H; Zhen Z; Zhou D; Chen H
    Transl Pediatr; 2023 Jan; 12(1):31-45. PubMed ID: 36798930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia.
    Yousef AM; Farhad R; Alshamaseen D; Alsheikh A; Zawiah M; Kadi T
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):755-762. PubMed ID: 30684021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.